Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
09/2005
09/14/2005EP1572875A2 Receptors and membrane-associated proteins
09/14/2005EP1572874A2 Antibodies that immunospecifically bind to trail receptors
09/14/2005EP1572872A2 Igs as modifiers of the p53 pathway and methods of use
09/14/2005EP1572871A2 T1r3 a novel taste receptor
09/14/2005EP1572868A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/14/2005EP1572867A2 Endothelial cell expression patterns
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572862A2 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
09/14/2005EP1572861A2 Ap1 amine oxidase variants
09/14/2005EP1572697A1 Novel spirobenzofuranlactams and the derivatives thereof, methods for the production thereof, and use thereof
09/14/2005EP1572117A2 Production of ubiquinones
09/14/2005EP1572073A2 Alteration of rab38 function to modulate mammalian pigmentation
09/14/2005EP1571968A2 Compositions and methods for the diagnosis and treatment of tumor
09/14/2005EP1337645B1 Rhodococcus cloning and expression vectors
09/14/2005EP1141674B1 A biofouling monitor and methods to monitor or detect biofouling
09/14/2005EP1109915B1 Nucleotide sequences for the tal gene
09/14/2005EP1082141B1 Cd40 binding antibodies and ctl peptides for treating tumors
09/14/2005EP1070255B1 Method to detect the complex of igfbp-3 with igf and/or als
09/14/2005EP1066395B1 Inducible alphaviral gene expression system
09/14/2005EP1013665B1 Polypeptide having water channel activity and dna sequence
09/14/2005EP0990039B1 Increasing production of proteins in gram-positive microorganisms
09/14/2005EP0988384B1 New beta-glucanase from a bacillus
09/14/2005CN1668754A Carotene synthase gene and uses therefor
09/14/2005CN1668741A Production of polyketides and other natural products
09/14/2005CN1668740A Recombinant type II restriction endonucleases, MmeI and related endonucleases and methods for producting the same
09/14/2005CN1668731A Genetically modified microorganisms, plasmid and fermentation process with the presence of flocculation regulated by medium changes
09/14/2005CN1668634A Detection of secreted polypeptides
09/14/2005CN1667116A Microorganism strain and method for converting cephalosporin C into deacetylate cephalosporin C by using same
09/14/2005CN1667115A Aspergillus niger strain and its use in solid fermentation production of pectinase
09/14/2005CN1666633A Production method of nutritious fungus feed addictive
09/14/2005CN1219052C Rice wine lactobacillus strain for producing bacteriocin and its use method
09/14/2005CN1219051C Method for producing Bicao anti-bateria spore using Bicao substrate
09/14/2005CN1219050C Transgenic saline algae bio-reactor
09/14/2005CN1219043C Tomato beverage and yeast for preparing the beverage
09/14/2005CN1218961C Osteoclast formation inhibitive factor, its nucleotide sequence and preparation method
09/14/2005CN1218626C Improved process for cultivation of algae
09/13/2005US6943281 Expression of Cry3B insecticidal protein in plants
09/13/2005US6943243 Control of gene expression in eukaryotic cells
09/13/2005US6943241 Full-length cDNA
09/13/2005US6943240 Nucleic acids for high throughput screening of CpG-based immuno-agonist/antagonist
09/13/2005US6943238 Antibodies to cyclin E2 protein
09/13/2005US6943150 Antiapoptosis polypeptides or fusion proteins coded by nucleic acids
09/13/2005US6943020 Death domain containing receptor-4 antibodies
09/13/2005US6943007 Treatment of cancer and AIDS
09/13/2005US6943005 Natural fibers has groove and cutting notch on surface, embedded with agar, for inoculating and cultivating microorganism in a medium, monitoring by a scanning electron microscope, promoting yeast growth and proliferation for food, sake brewing
09/13/2005US6943004 A zinc resist Alcaligenes microorganism, culturing in presence of zinc, isolated nucleic acid sequence, vectors, zinc-resistant host cell; high production rate; enzyme has optical purity, used for making antibiotics, peptide drug
09/13/2005US6942998 Process for generation of hydrogen gas from various feedstocks using thermophilic bacteria
09/13/2005US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides
09/13/2005US6942991 Nucleotide sequences coding for polypeptides endowed with a larvicidal activity towards Lepidoptera
09/13/2005US6942990 Glutaryl cephalosporin amidase from Pseudomonas diminuta BS-203
09/13/2005US6942986 Detecting inducer in sample; obtain sample, incubate with bacterial extract, measure light generated by bacteria,
09/13/2005US6942983 An isolated monoclonal antibody is used for binding and detecting a polypeptide having amino acid sequence with valine at residue 835, modulate kinase activity in cells, protein kinase C
09/13/2005US6942979 Method for screening substances capable of modulating the activity of a TRAAK potassium channel
09/13/2005US6942863 Polypeptide for use the prevention of infections associated with tissue grafting
09/13/2005US6942860 For use against plant parasitic nematodes; waste treatment
09/13/2005US6942857 Lactobacillus reuteri PRD202(KCTC-10301BP) which converts monosaccharides and disaccharides into intestinal nonabsorb-able polysaccharides
09/13/2005US6942853 Latent fusion protein
09/13/2005US6942849 Incorporation of exogenous lactic bacteria into the oral microflora
09/13/2005US6942169 Micromachined lysing device and method for performing cell lysis
09/13/2005CA2335394C Aerothricin analogs, their preparation and use
09/13/2005CA2218299C Bacteria having nematicidal activity and their agricultural use
09/13/2005CA2175476C Opioid receptor: compositions and methods
09/13/2005CA2165940C Process for the preparation of pyruvic acid
09/12/2005CA2497799A1 Acetolactate synthase gene promoter
09/10/2005CA2500033A1 Methods for isolation of bacteria from biological samples
09/09/2005WO2005083427A1 A method of assaying specification of lymphocyte activation
09/09/2005WO2005083108A1 Reduction of spontaneous mutation rates in cells
09/09/2005WO2005083102A1 Process for producing optically active 1,4-benzodioxin-2-carboxylic acid derivative
09/09/2005WO2005083090A1 Method of inducing homologous recombination
09/09/2005WO2005083087A1 Transgennic animal allowing inductive deletion of osteocytes
09/09/2005WO2005083078A1 Method, chip, device and system for extraction of biological materials
09/09/2005WO2005083077A1 Process for producing amino acid
09/09/2005WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof
09/09/2005WO2005083056A1 Solid cellulosic culture medium and process for producing the same
09/09/2005WO2005083055A1 Culture methods for cryptosporidium
09/09/2005WO2005083054A1 Method and device for thermal conditioning of a cell
09/09/2005WO2005082930A2 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
09/09/2005WO2005082149A1 Method of controlling plant disease damage by using bacillus and controlling agent
09/09/2005WO2005056818A8 Electrochemical assay for the identification of microorganisms
09/09/2005WO2005049853A3 Compositions and methods for screening pro-apoptotic compounds
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005CA2557729A1 Reduction of spontaneous mutation rates in cells
09/09/2005CA2557490A1 Generation of recombinant genes in prokaryotic cells by using two extrachromosomal elements
09/09/2005CA2557486A1 Method, chip, device and system for extraction of biological materials
09/09/2005CA2557481A1 Culture methods for cryptosporidium
09/09/2005CA2555413A1 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
09/09/2005CA2552351A1 Method for determination and quantification of radiation or genotoxin exposure
09/08/2005US20050197497 Used to improve the therapeutic efficacy of current cancer treatment; sensitizing cancerous cells to treatment with conventional anti-tumor drugs
09/08/2005US20050197491 Comprises brain glycoprotein for use in identifying modulators which can be used in diagnosis and treatment of nervous system disorders
09/08/2005US20050197384 water or organic solvent extract of mycelium of Antrodia Camphorata; has central cholinergic agonism, hepatoprotection, anti-inflammation or anti-tumor activity
09/08/2005US20050197379 neuroprotective and neuroregenerative compositions; produced by actinomycete strains
09/08/2005US20050197295 Modified annexin proteins and methods for preventing thrombosis
09/08/2005US20050196866 Transforming the host cell with one or more genes that encode at least one enzyme that uses NADPH as a cofactor; pyridine nucleotide transhydrogenase that catalyzes NADPH formation; cell produces at least 50% more NADPH after transformation
09/08/2005US20050196849 Methods for forming structurally defined organic molecules
09/08/2005US20050196848 Process for the fermentative production of L-amino acids by attenuation of the poxB gene
09/08/2005US20050196846 Transgenic coryneform for use as bioreactor in fermentation of glutamic acid for use in medicine, foods and animal feeds
09/08/2005US20050196838 Reduced immunogenicity; increased affinity and avidity; improved cell culturing
09/08/2005US20050196837 DNA construct comprising centromeric, telomeric and genomic regions for use in transfer of heterologous sequences into cells
09/08/2005US20050196836 Gamma-glutamylcysteine producing yeast
09/08/2005US20050196833 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods